Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Out-of-Hospital Cardiac Arrest | 10 | 2022 | 89 | 6.120 |
Why?
|
| Emergency Medical Services | 10 | 2022 | 429 | 5.010 |
Why?
|
| Cardiopulmonary Resuscitation | 9 | 2022 | 318 | 3.910 |
Why?
|
| Intubation, Intratracheal | 8 | 2022 | 445 | 2.540 |
Why?
|
| Airway Management | 7 | 2022 | 102 | 2.510 |
Why?
|
| Heart Arrest | 3 | 2022 | 358 | 1.300 |
Why?
|
| Carbon Dioxide | 2 | 2017 | 313 | 1.120 |
Why?
|
| Sepsis | 2 | 2021 | 652 | 1.020 |
Why?
|
| Algorithms | 11 | 2020 | 3890 | 1.000 |
Why?
|
| Movement | 7 | 2020 | 556 | 0.980 |
Why?
|
| Resuscitation | 3 | 2019 | 223 | 0.890 |
Why?
|
| Amiodarone | 1 | 2022 | 42 | 0.820 |
Why?
|
| Pandemics | 2 | 2021 | 1559 | 0.790 |
Why?
|
| Convalescence | 1 | 2021 | 25 | 0.780 |
Why?
|
| Blood Donors | 1 | 2021 | 164 | 0.740 |
Why?
|
| Donor Selection | 1 | 2021 | 110 | 0.720 |
Why?
|
| Laryngoscopes | 1 | 2021 | 86 | 0.700 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 10 | 2016 | 2370 | 0.610 |
Why?
|
| Oxygen | 2 | 2017 | 754 | 0.560 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 333 | 0.560 |
Why?
|
| Medicare | 2 | 2021 | 860 | 0.550 |
Why?
|
| Radiotherapy Setup Errors | 1 | 2016 | 80 | 0.540 |
Why?
|
| Immobilization | 1 | 2016 | 93 | 0.540 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 399 | 0.540 |
Why?
|
| Cognition | 1 | 2021 | 968 | 0.510 |
Why?
|
| Radiosurgery | 3 | 2016 | 1330 | 0.500 |
Why?
|
| Patient Positioning | 1 | 2016 | 195 | 0.490 |
Why?
|
| Clinical Competence | 2 | 2020 | 1270 | 0.460 |
Why?
|
| Quality of Health Care | 1 | 2018 | 621 | 0.440 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 651 | 0.420 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 715 | 0.420 |
Why?
|
| Stroke | 1 | 2020 | 1144 | 0.390 |
Why?
|
| Quality Improvement | 1 | 2018 | 851 | 0.380 |
Why?
|
| Artifacts | 3 | 2008 | 532 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2014 | 7551 | 0.330 |
Why?
|
| Humans | 38 | 2022 | 261506 | 0.320 |
Why?
|
| Head and Neck Neoplasms | 6 | 2016 | 3976 | 0.310 |
Why?
|
| Spinal Neoplasms | 2 | 2009 | 631 | 0.280 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2008 | 255 | 0.270 |
Why?
|
| Defibrillators | 1 | 2005 | 25 | 0.270 |
Why?
|
| Reproducibility of Results | 7 | 2020 | 6009 | 0.260 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2007 | 582 | 0.260 |
Why?
|
| Male | 22 | 2022 | 123000 | 0.260 |
Why?
|
| Intestine, Small | 2 | 2007 | 499 | 0.250 |
Why?
|
| Sialoglycoproteins | 1 | 2004 | 151 | 0.250 |
Why?
|
| United States | 5 | 2022 | 15433 | 0.240 |
Why?
|
| Adult | 12 | 2021 | 77950 | 0.230 |
Why?
|
| Prostatic Neoplasms | 8 | 2008 | 5767 | 0.230 |
Why?
|
| Granulocytes | 1 | 2004 | 224 | 0.230 |
Why?
|
| Radiotherapy, Intensity-Modulated | 5 | 2016 | 2104 | 0.220 |
Why?
|
| Radiotherapy Dosage | 10 | 2016 | 3842 | 0.220 |
Why?
|
| Procainamide | 1 | 2022 | 13 | 0.210 |
Why?
|
| Cause of Death | 1 | 2005 | 752 | 0.210 |
Why?
|
| Intestinal Mucosa | 2 | 2007 | 1081 | 0.210 |
Why?
|
| Information Systems | 1 | 2022 | 54 | 0.210 |
Why?
|
| Hospitalization | 2 | 2021 | 2083 | 0.210 |
Why?
|
| Lidocaine | 1 | 2022 | 76 | 0.210 |
Why?
|
| Thyroid Gland | 1 | 2004 | 355 | 0.200 |
Why?
|
| Female | 16 | 2022 | 141928 | 0.200 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 592 | 0.190 |
Why?
|
| Middle Aged | 12 | 2021 | 86204 | 0.190 |
Why?
|
| Prospective Studies | 3 | 2021 | 12873 | 0.190 |
Why?
|
| Incidence | 2 | 2021 | 5673 | 0.190 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 226 | 0.180 |
Why?
|
| Immunization, Passive | 1 | 2021 | 172 | 0.180 |
Why?
|
| Executive Function | 1 | 2021 | 160 | 0.180 |
Why?
|
| Neuromuscular Blockade | 1 | 2019 | 16 | 0.180 |
Why?
|
| Geography | 1 | 2020 | 140 | 0.180 |
Why?
|
| Tracheotomy | 1 | 2019 | 27 | 0.180 |
Why?
|
| Antigens, CD | 1 | 2004 | 1385 | 0.180 |
Why?
|
| Pulmonary Ventilation | 1 | 2019 | 45 | 0.170 |
Why?
|
| Manikins | 1 | 2020 | 137 | 0.170 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2007 | 1648 | 0.170 |
Why?
|
| Aged | 9 | 2021 | 70117 | 0.170 |
Why?
|
| Urban Population | 1 | 2020 | 269 | 0.170 |
Why?
|
| Biomechanical Phenomena | 1 | 2020 | 338 | 0.170 |
Why?
|
| Laryngoscopy | 1 | 2021 | 183 | 0.170 |
Why?
|
| Lymphocytes | 1 | 2004 | 1234 | 0.170 |
Why?
|
| Liver | 1 | 2008 | 2961 | 0.160 |
Why?
|
| Prostate | 4 | 2008 | 1088 | 0.160 |
Why?
|
| Sensitivity and Specificity | 4 | 2020 | 4971 | 0.160 |
Why?
|
| Rural Population | 1 | 2020 | 281 | 0.160 |
Why?
|
| Health Services Research | 1 | 2020 | 233 | 0.160 |
Why?
|
| Hospitals | 1 | 2022 | 485 | 0.160 |
Why?
|
| Seminal Vesicles | 3 | 2008 | 152 | 0.160 |
Why?
|
| Mortality | 1 | 2020 | 343 | 0.160 |
Why?
|
| Hypercapnia | 1 | 2017 | 26 | 0.160 |
Why?
|
| Radiotherapy | 1 | 2005 | 1824 | 0.150 |
Why?
|
| Learning | 1 | 2021 | 403 | 0.150 |
Why?
|
| Machine Learning | 1 | 2020 | 319 | 0.150 |
Why?
|
| Blood Gas Analysis | 1 | 2017 | 100 | 0.150 |
Why?
|
| Dendritic Cells | 1 | 2004 | 1085 | 0.150 |
Why?
|
| Macrophages | 1 | 2004 | 1304 | 0.150 |
Why?
|
| Cohort Studies | 2 | 2020 | 9244 | 0.150 |
Why?
|
| Retrospective Studies | 6 | 2022 | 37905 | 0.150 |
Why?
|
| Neuropsychological Tests | 1 | 2021 | 1178 | 0.150 |
Why?
|
| Leukosialin | 2 | 2007 | 16 | 0.140 |
Why?
|
| Health Care Surveys | 1 | 2018 | 430 | 0.140 |
Why?
|
| Radiotherapy, Conformal | 3 | 2008 | 902 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2008 | 2027 | 0.140 |
Why?
|
| Benchmarking | 1 | 2018 | 273 | 0.140 |
Why?
|
| Radiographic Image Enhancement | 2 | 2008 | 402 | 0.130 |
Why?
|
| Hypoxia | 1 | 2017 | 443 | 0.120 |
Why?
|
| Bayes Theorem | 1 | 2019 | 1021 | 0.120 |
Why?
|
| Re-Irradiation | 1 | 2016 | 163 | 0.120 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2016 | 304 | 0.110 |
Why?
|
| Parotid Gland | 3 | 2007 | 112 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2019 | 929 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 14889 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2008 | 4557 | 0.100 |
Why?
|
| Time Factors | 2 | 2021 | 12926 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 925 | 0.100 |
Why?
|
| Pelvic Bones | 2 | 2008 | 95 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 4314 | 0.090 |
Why?
|
| Mediastinal Neoplasms | 1 | 2014 | 423 | 0.090 |
Why?
|
| Rectum | 3 | 2006 | 467 | 0.090 |
Why?
|
| Registries | 1 | 2017 | 2170 | 0.090 |
Why?
|
| Child | 2 | 2022 | 29154 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2020 | 32848 | 0.090 |
Why?
|
| Texas | 1 | 2020 | 6311 | 0.090 |
Why?
|
| Phantoms, Imaging | 2 | 2005 | 1271 | 0.090 |
Why?
|
| Exhalation | 1 | 2008 | 60 | 0.080 |
Why?
|
| Rotation | 1 | 2008 | 112 | 0.080 |
Why?
|
| Body Burden | 1 | 2008 | 65 | 0.080 |
Why?
|
| CD3 Complex | 2 | 2007 | 314 | 0.080 |
Why?
|
| Dental Prosthesis | 1 | 2007 | 4 | 0.080 |
Why?
|
| Heart | 1 | 2014 | 1223 | 0.080 |
Why?
|
| Radiology Information Systems | 1 | 2008 | 114 | 0.080 |
Why?
|
| Muscles | 1 | 2008 | 416 | 0.070 |
Why?
|
| Interleukin-18 | 1 | 2007 | 100 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 3 | 2004 | 4367 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 29902 | 0.070 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2006 | 126 | 0.070 |
Why?
|
| Head | 1 | 2007 | 249 | 0.070 |
Why?
|
| Hodgkin Disease | 1 | 2014 | 1429 | 0.070 |
Why?
|
| Electric Countershock | 1 | 2005 | 71 | 0.070 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2004 | 84 | 0.060 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2004 | 182 | 0.060 |
Why?
|
| Emergency Treatment | 1 | 2005 | 105 | 0.060 |
Why?
|
| Neck | 1 | 2007 | 383 | 0.060 |
Why?
|
| Thyrotropin, beta Subunit | 1 | 2004 | 5 | 0.060 |
Why?
|
| CD11 Antigens | 1 | 2004 | 23 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2007 | 1144 | 0.060 |
Why?
|
| Early Diagnosis | 1 | 2005 | 298 | 0.060 |
Why?
|
| B7-1 Antigen | 1 | 2004 | 88 | 0.060 |
Why?
|
| Probability | 1 | 2005 | 866 | 0.060 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2006 | 361 | 0.060 |
Why?
|
| Th2 Cells | 1 | 2004 | 257 | 0.060 |
Why?
|
| Lymphocyte Activation | 2 | 2007 | 1688 | 0.060 |
Why?
|
| Th1 Cells | 1 | 2004 | 250 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2008 | 769 | 0.060 |
Why?
|
| Receptors, Chemokine | 1 | 2003 | 114 | 0.060 |
Why?
|
| Lung | 1 | 2014 | 3151 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2004 | 2314 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 2003 | 216 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2004 | 842 | 0.050 |
Why?
|
| Neoplasms | 1 | 2008 | 15193 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2007 | 2508 | 0.050 |
Why?
|
| Radiometry | 1 | 2008 | 980 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2004 | 478 | 0.050 |
Why?
|
| Thyrotropin | 1 | 2002 | 119 | 0.050 |
Why?
|
| Chemokines | 1 | 2003 | 314 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 1399 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2004 | 1062 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2004 | 2450 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2007 | 1586 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2005 | 785 | 0.050 |
Why?
|
| International Classification of Diseases | 1 | 2021 | 83 | 0.050 |
Why?
|
| Drug Overdose | 1 | 2021 | 81 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2005 | 1145 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 943 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 2173 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2004 | 4143 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2019 | 100 | 0.040 |
Why?
|
| Homeostasis | 1 | 2004 | 950 | 0.040 |
Why?
|
| Medicaid | 1 | 2021 | 279 | 0.040 |
Why?
|
| Mice | 5 | 2007 | 34495 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2007 | 6942 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 3639 | 0.040 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2009 | 2326 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 4988 | 0.040 |
Why?
|
| Proton Therapy | 1 | 2007 | 1577 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2007 | 7226 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 3022 | 0.030 |
Why?
|
| Cytokines | 1 | 2004 | 2809 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2008 | 11538 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2004 | 5710 | 0.030 |
Why?
|
| Animals | 5 | 2007 | 59536 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1148 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 3260 | 0.030 |
Why?
|
| Urinary Bladder | 2 | 2006 | 575 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2005 | 6869 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2014 | 726 | 0.030 |
Why?
|
| Survival Rate | 1 | 2005 | 12221 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 1371 | 0.020 |
Why?
|
| Organs at Risk | 1 | 2014 | 514 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2008 | 1863 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2004 | 5437 | 0.020 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2007 | 2 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 2007 | 53 | 0.020 |
Why?
|
| Breast | 1 | 2014 | 1344 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 337 | 0.020 |
Why?
|
| Reference Standards | 1 | 2008 | 339 | 0.020 |
Why?
|
| Tonsillar Neoplasms | 1 | 2007 | 80 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2007 | 205 | 0.020 |
Why?
|
| Elasticity | 1 | 2006 | 156 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 699 | 0.020 |
Why?
|
| Subtraction Technique | 1 | 2006 | 141 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2008 | 467 | 0.020 |
Why?
|
| Tomography, X-Ray | 1 | 2005 | 13 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2007 | 295 | 0.020 |
Why?
|
| Observer Variation | 1 | 2007 | 671 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 671 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2007 | 690 | 0.010 |
Why?
|
| Receptors, CCR | 1 | 2003 | 4 | 0.010 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2003 | 10 | 0.010 |
Why?
|
| Chemokines, CC | 1 | 2003 | 36 | 0.010 |
Why?
|
| Muramidase | 1 | 2003 | 110 | 0.010 |
Why?
|
| Cheek | 1 | 2003 | 70 | 0.010 |
Why?
|
| Antigens | 1 | 2003 | 292 | 0.010 |
Why?
|
| Biotinylation | 1 | 2002 | 47 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 329 | 0.010 |
Why?
|
| Particle Accelerators | 1 | 2004 | 352 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2007 | 3033 | 0.010 |
Why?
|
| Pain | 1 | 2009 | 1658 | 0.010 |
Why?
|
| Epithelium | 1 | 2003 | 720 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 777 | 0.010 |
Why?
|
| Rabbits | 1 | 2002 | 957 | 0.010 |
Why?
|
| Contrast Media | 1 | 2007 | 1472 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 2049 | 0.010 |
Why?
|
| Weight Loss | 1 | 2004 | 627 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 1489 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2004 | 2803 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 10001 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 21713 | 0.010 |
Why?
|
| Peptides | 1 | 2002 | 1479 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2004 | 2967 | 0.010 |
Why?
|
| Rats | 1 | 2002 | 6086 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 4053 | 0.010 |
Why?
|